Professional Documents
Culture Documents
David Zagzag, MD, Ph.D. Recognized As A Professional of The Year For 2020 by Strathmore's Who's Who Worldwide
David Zagzag, MD, Ph.D. Recognized As A Professional of The Year For 2020 by Strathmore's Who's Who Worldwide
Rego Park, NY, June 28, 2020 --(PR.com)-- David Zagzag, MD, Ph.D. of Rego Park, New York has
been recognized as a Professional of the Year for 2020 by Strathmore’s Who’s Who Worldwide Edition
for his outstanding achievements and contributions in the medical field.
With over 30 years experience, Dr. Zagzag specializes in Neuropathology and is Board Certified in
Anatomic Pathology and Neuropathology. He serves as the Chief of the Division of Neuropathology and
is the Director of the Human Brain Tumor Bank. The clinical laboratory accessions more than 1,900
neurological specimens per year, including over 550 tumors cases that range from stereotaxic biopsies to
gross resections, as well as many infectious and epileptic cases.
At NYU, Dr. Zagzag teaches medical students, is training residents and fellows, and mentors Ph.D. and
MD/Ph.D. graduate students. He has earned the NYU Grossman School of Medicine Teacher of the Year
Award in 2005 and 2008, and the NYU All University Distinguished Teaching Award in 2010.
Dr. Zagzag is the Director of the Microvascular and Molecular Neuro-Oncology Laboratory at NYU
Langone Medical Center, a basic and translational research lab where research seeks to elucidate the
expression patterns, trigger mechanisms, pathophysiological and molecular mechanisms implicated in
glioma progression especially as it relates to hypoxia, tumor microenvironment, vascular regression,
angiogenesis and invasion. The laboratory also aims to investigate novel genetic and molecular
mechanisms linked to von Hippel-Lindau disease, in which highly-vascularized tumors develop
throughout the body. His long-term goal is to discover new therapeutic approaches that would improve
survival outcomes in patients with brain tumors. His efforts have been supported by various grants,
including from the Children’s Brain Tumor Foundation, the Goldhirsh Foundation, the Elsa Pardee
Foundation, the Making Headway Foundation, the Musella Foundation, the American Cancer Society,
and the National Institutes of Health. He has written over 240 peer-reviewed journal articles, reviews,
several book chapters and edited a book on the molecular diagnosis of brain tumors. He is affiliated with
the World Health Organization, the American Association of Neuropathologists and the Society for
Neuro-Oncology.
Dr. Zagzag has served as an expert scientific advisor for the boards of several brain tumor foundations
such as the Children’s Brain Tumor Foundation and is the current Chair of the Professional Advisory
Page 1/3
PR.com Press Release Distribution Terms of Use
Board of the Gli-Hope Foundation. He also served on the Awards Committee and Program Committee of
the American Association of Neuropathologists, and was a permanent member and co-chairman of the
American Cancer Society study section. In addition, Dr. Zagzag has been invited to serve as a reviewer
for the National Institutes of Health study sections, and sits on the editorial advisory board of several
renowned scientific journals. Dr. Zagzag has also received numerous awards as an outstanding
physician-scientist, including the Lucien J. Rubinstein Award in Neuro-Oncology (American Association
of Neuropathologists), the Award for Excellence in Clinical Science (Society for Neuro-Oncology) and
the Pioneer Award for Pediatric Neuropathology. Dr. Zagzag is an internationally known pioneer that has
received numerous invitations to lecture at distinguished universities in the United States, Canada, South
America and Europe. He is fluent in English and French. In his spare time, David enjoys family activities
and antiques.
Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Strathmore Worldwide
Susan Perrault
516-677-9696
Contact via Email
www.strathmoreworldwide.com
Syndi Reibman
News Image:
Page 3/3
PR.com Press Release Distribution Terms of Use